来自免疫细胞的细胞外囊泡:在瘤治疗中的作用
Yuanyuan Shi1, Fei Yao2, Yao Yin1
1State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning 530021, China.
International immunopharmacology
|April 26, 2024
概括
来自免疫细胞的细胞外囊泡 (EV) 影响瘤生长和转移. 这篇评论探讨了它们的组成,免疫效应和癌症治疗中的治疗潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
背景情况:
- 细胞外囊泡 (EVs) 是参与细胞间通信的脂质纳米大小结构.
- 免疫细胞衍生的EVs影响瘤进展,转移和免疫反应.
- 电动汽车作为生物标志物,药物输送工具和疫苗开发具有重大潜力.
研究的目的:
- 审查来自先天和适应性免疫细胞的EVs的组成.
- 讨论这些电动汽车对免疫系统的影响.
- 探索免疫细胞衍生的EVs在癌症治疗中的应用.
主要方法:
- 文献综述侧重于免疫细胞衍生的细胞外囊泡.
- 对EV含量,免疫调节和癌症治疗应用的分析.
- 综合当前关于挑战和未来前景的研究.
主要成果:
- 免疫细胞EV含有影响细胞间通信的活性成分.
- 这些EV可以调节与癌症相关的刺激性和抑制性免疫反应.
- 电动汽车在癌症诊断,预后和治疗方面表现有前途.
结论:
- 了解免疫细胞EV组成对于治疗开发至关重要.
- 电动汽车为新的癌症治疗策略提供了一个有希望的途径.
- 需要进一步的研究来克服局限性,并充分实现电动汽车的治疗潜力.
相关概念视频
Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


